The quiet consolidator giving America's best medical spas capital, operations and cover - without taking away what made them work.
Annie Aesthetic's mark. A New-York-based medical-aesthetics holding company that partners with, rather than replaces, the medspa owners it acquires.
Annie Aesthetic is a medical-aesthetics holding company that partners with and acquires leading medical spas across the United States. Where a solo clinic owner has to be both a great clinician and an accidental CFO, marketer, recruiter and compliance officer, Annie Aesthetic takes the second job off their plate. It buys profitable clinics, then centralizes the parts of the business that have nothing to do with treating a patient - capital, operations, marketing, hiring, technology and legal.
The company was incubated in May 2022 by Tucker's Farm Corporation, a lower-middle-market private equity holding company, and launched with roughly $30 million of equity capital as a permanent-capital vehicle. In about three years it has grown into a network of 12 of the nation's leading medical-aesthetics brands doing an estimated $65 million in revenue - all supported by a corporate team of roughly 27 people.
The pitch to clinic founders is deliberately un-flashy. Annie Aesthetic describes itself as "the best-in-class partner or buyer for leading medical spa owners across the USA," and it usually keeps the existing operating team in place rather than parachuting in new management. Its podcast appearance was titled, fittingly, "Leading Quietly, Growing Boldly."
We are always looking for Win-Win-Win opportunities - for business owners, for our teams in the clinics, and for patients.
Annie Aesthetic has two audiences. The first is the medspa owner who wants to sell or partner for growth. CEO Sam Schloss looks specifically for top-tier brands with good retention rates and a sticky, repeat customer base - clinics where clients keep coming back. The second audience is the patients of the 12 partner brands, who ultimately judge whether the platform's promise of consistent, high-quality care holds up.
The problem sits between them. The medical-aesthetics market is fragmenting and consolidating at the same time: new clinics open constantly, and the good ones quickly hit a ceiling built out of everything that isn't skincare - hiring, marketing spend, multi-state licensing, capital for a second location. Many owners are excellent practitioners who were never trained to run a scaling company, and the traditional fix - sell to a private equity buyer who replaces you - risks gutting the very thing that made the clinic worth buying.
Annie Aesthetic's answer is to be the buyer it says most owners actually want: one that supplies the back office and the capital, keeps the founder and team in place, and treats the transaction as the start of a long-term partnership rather than an exit.
Funding for expansion, add-on acquisitions and new treatment centers, backed by equity investors and an expanding credit facility.
Data-driven operations support and modern clinic systems that give solo owners real operating leverage.
Data-driven marketing to sharpen customer acquisition and protect the retention that makes a clinic valuable.
Recruitment, talent management and HR administration handled centrally for partner clinics.
Implementation of cutting-edge clinic technology and platforms across the network.
Compliance, licensing and regulatory support for medical practices operating across state lines.
Structurally, Annie Aesthetic is a permanent-capital holding company - a roll-up, in plainer terms. It takes majority or full ownership of profitable medspa clinics, folds them into a shared operating platform, and grows revenue both organically and through further acquisitions. Rather than the fixed-life fund model that forces a sale on a timeline, permanent capital lets it hold and compound.
The deal menu is deliberately flexible. Owners can take an all-cash payout, roll equity forward to keep minority ownership in the larger platform, or accept an earn-out or seller note that pays part upfront and the rest over time. Non-competes and non-solicits are standard, as in any M&A deal, but Annie Aesthetic says it aims to be reasonable, and it keeps information requests light until a valuation is agreed.
Figures reported publicly by the company and press; 2022 bar reflects launch equity capital, 2025 reflects revenue run-rate. Approximate.
| Round | Date | Amount | Investors |
|---|---|---|---|
| Seed / Incubation | May 2022 | ~$30M equity | Tucker's Farm Corporation |
| Series A | 2024 | Undisclosed (valuation reported >$100M) | InterAlpen Partners |
| Series B | Sep 2025 | Undisclosed (+ expanded credit facility) | InterAlpen Partners, Brookside Equity Partners, Plexus Capital |
The lineage is unusual. Tucker's Farm Corporation - the parent that incubated Annie Aesthetic - began life as a goat dairy in Bermuda in 1994 before becoming a private equity firm deploying tens of millions a year into lower-middle-market businesses. Legal counsel Dykema advised on both the Series A, closed above a $100 million valuation, and the 2025 Series B.
The medspa roll-up space is crowded - names like MedSpa Partners and Advanced MedAesthetic Partners chase the same fragmented market, and any owner can also sell to a generalist private equity buyer or simply stay independent. Annie Aesthetic's differentiation is less about the mechanics of a deal and more about its posture.
It leads with values it states plainly - "integrity, kindness and patient care above all else" - and a self-described "play-no-games" policy: light early diligence, a transparent process, and quick valuation feedback so owners don't rack up costs before they know if there's a fit. Its operations team is made up of industry veterans and its deal team of M&A professionals, a pairing meant to reassure sellers that the people buying their clinic understand both the spreadsheet and the treatment room.
In an industry where an acquirer's reputation travels fast between clinic owners, that posture is the product. Keeping founders in the chair and teams on payroll isn't a soft gesture - in a business where sticky patient relationships are the asset, continuity is what protects the value being bought.
If you are looking to sell or partner for growth, this is a world class team.
Annie Aesthetic launches as a permanent-capital vehicle for medical aesthetics with roughly $30 million of equity capital.
Begins partnering with and acquiring leading medspa brands, keeping operating teams in place.
Closes a Series A led by InterAlpen Partners at a reported valuation of more than $100 million to fund add-on acquisitions.
Closes a Series B with Brookside Equity Partners and Plexus Capital, expands its credit facility, and reaches roughly $65M across 12 brands.
An inside look at the low-profile consolidator quietly rolling up America's best medspas.
Profiles CEO Sam Schloss and the seller-friendly deal philosophy behind Annie Aesthetic.
Traces how a Bermuda goat-cheese business became the PE firm that launched Annie Aesthetic.
Breaks down the flexible transaction structures the company offers medspa sellers.
Examines the claim that owners, staff and patients can all come out ahead of a deal.
Why Annie Aesthetic targets clinics with sticky, repeat customer bases.
It is a medical-aesthetics holding company that partners with and acquires leading U.S. medical spas, then provides them with capital, operations, marketing, recruiting, technology and legal support to grow.
It was co-founded by Sam Schloss (CEO), who came from investment banking and private equity, and incubated by Tucker's Farm Corporation in May 2022.
As of 2025 it operated a network of 12 medical-aesthetics brands with roughly $65 million in revenue run-rate and about 27 corporate employees.
Flexibly - all-cash payouts, equity rollover for minority ownership, earn-outs or seller notes - and it typically keeps the existing operating team in place with competitive compensation.
Investors include Tucker's Farm Corporation, InterAlpen Partners (Series A and B lead), Brookside Equity Partners and Plexus Capital.